Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03736421 · ClinicalTrials.gov registry record
Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- 50
- Enrollment target
NCT03736421 is a clinical trial that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT03736421 was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The overall goal of this multicenter project is to characterize the expected normal range of Peripheral IntraVenous Volume Analysis (PIVA) values during a euvolemic state, and how those ranges may be altered by comorbidities; the relationship between PIVA and intravenous volume administration during resuscitation of infected patients with presumed hypovolemia; and, the relationship between PIVA and volume decreases during diuresis in acute heart failure patients with hypervolemia.
Interventions
- PROCEDURE Peripheral Intravenous Analysis (PIVA)
- PROCEDURE Non-invasive fluid response measure
- DIAGNOSTIC_TEST Passive leg raise (PLR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-11-10 |
| Est. Completion | 2021-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03736421
The ClinicalTrials.gov registry entry for NCT03736421 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Peripheral Intravenous Analysis (PIVA) is the first listed.
NCT03736421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03736421 about?
NCT03736421 is a clinical study titled "Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients". The overall goal of this multicenter project is to characterize the expected normal range of Peripheral IntraVenous Volume Analysis (PIVA) values during a euvolemic state, and how those ranges may be altered by comorbidities; the relationship between PIVA and intravenous volume administration during...
What is the current status of trial NCT03736421?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2018-11-10. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT03736421?
The interventions under investigation include: Peripheral Intravenous Analysis (PIVA) (PROCEDURE), Non-invasive fluid response measure (PROCEDURE), Passive leg raise (PLR) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03736421?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.